Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada

Clinical trial NCT00334750 · COMPLETED

Trial details

NCT number: NCT00334750
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Glaucoma, Open-Angle Ocular Hypertension

Start date: 2007-11-01
Primary completion: 2009-04-01
Enrollment: 410

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.